Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncorus, Inc. | Director | Stock Option (right to buy) | 12.5K | Jun 23, 2022 | Direct | ||
Flexion Therapeutics Inc | Director | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
Flexion Therapeutics Inc | Director | Stock option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONCR | Oncorus, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 9 | -$76.5K | 4 | Nov 19, 2021 | Director |
FLXN | Flexion Therapeutics Inc | Jun 24, 2021 | 2 | $0 | 4 | Jun 28, 2021 | Director |
ONCR | Oncorus, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
ONCR | Oncorus, Inc. | Dec 11, 2020 | 1 | $0 | 4/A | Jun 17, 2021 | Director |